Medications

'Significant' COVID-19 drug breakthrough

A new inhalation treatment for preventing the spread of COVID-19 is potentially far more effective than currently existing versions, according to new research carried out at the University of St Andrews.

Psychology & Psychiatry

Uncovering the source of inflammatory malaise

(Medical Xpress)—A study conducted by researchers at Emory indicates that inflammation targets a part of the brain called the basal ganglia, causing symptoms of depression and fatigue. The study was recently reported in ...

Immunology

Researchers answer long-standing question about lupus

For years, biomedical researchers have suspected that a specific set of immune cells are responsible for causing disease in lupus patients, but until now they haven't known for sure one way or the other.

HIV & AIDS

Research deciphers HIV attack plan

(Medical Xpress)—A new study by Los Alamos National Laboratory and University of Pennsylvania scientists defines previously unknown properties of transmitted HIV-1, the virus that causes AIDS. The viruses that successfully ...

Diseases, Conditions, Syndromes

Will new drugs block hepatitis C virus in its tracks?

Targeted multi-drug treatments for hepatitis C patients that could stop the virus in its tracks have come a step closer, thanks to researchers at the University of Leeds, UK.

Immunology

Interferon shows promise as flu therapy

A molecule the body produces naturally in response to virus infection could be a viable flu treatment in the future, suggest researchers at the Francis Crick Institute in London.

Diseases, Conditions, Syndromes

Hypertension ups retinopathy risk with HCV treatment

(HealthDay) -- For patients with hepatitis C virus (HCV) treated with pegylated interferon alpha (PegIFNα) and ribavirin, retinopathy occurs frequently, especially in those with hypertension, according to a study published ...

page 1 from 2